Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - betula papyrifera, quantity: 1.7 ml (equivalent: betula papyrifera, qty 17 mg/ml); betula nigra, quantity: 1.7 ml (equivalent: betula nigra, qty 17 mg/ml); betula pendula, quantity: 1.7 ml (equivalent: betula pendula, qty 17 mg/ml) - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

alk-abello, inc. - quercus rubra pollen (unii: svw19et93c) (quercus rubra pollen - unii:svw19et93c), quercus alba pollen (unii: z4y9zsv4kk) (quercus alba pollen - unii:z4y9zsv4kk), quercus virginiana pollen (unii: 8kdg09a4go) (quercus virginiana pollen - unii:8kdg09a4go) - crab leg, unspecified 0.1 g in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust, molds, animal danders, various other inhalants, and in situations where the offending allergen cannot be avoided. prior to initiation of therapy, the clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms, ige antibodies, positive skin tests, or properly controlled challenge testing. in most cases, immunotherapy is not indicated for those allergens that can be eliminated or minimized by environmental control. patients on beta-blockers are not candidates for immunotherapy, as they can be non-responsive to beta-agonists that may be required to reverse a systemic reaction (also see warnings and adverse

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

jubilant hollisterstier llc - ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3) - ambrosia artemisiifolia pollen 0.05 g in 1 ml - short ragweed pollen allergenic extract and short and giant ragweed pollen mix allergenic extract are indicated for: - skin test diagnosis of patients with a clinical history of allergy to ragweed pollen (short ragweed or short and giant ragweed pollen). - immunotherapy for the reduction of ragweed pollen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for pollen-specific ige antibodies for short and/or giant ragweed pollen. short ragweed pollen and short and giant ragweed pollen mix allergenic extracts are contraindicated in individuals with the following conditions: - severe, unstable or uncontrolled asthma. - history of any severe systemic reaction to the allergen extract when administered for diagnosis or treatment. - medical condition that reduces the ability to survive anaphylaxis. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes.  in the u.s.  general population, the estimated background risk of major birth defects and miscarria

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts); allergen extracts 1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts); allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) - solution for injection - active: allergen extracts 0.1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract); allergen extracts 1 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract); allergen extracts 10 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract) - solution for injection - active: allergen extracts 0.1 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Canada - Tiếng Anh - Health Canada

greer laboratories inc - standardized kentucky blue/june grass pollen; standardized meadow fescue grass pollen; standardized orchard grass pollen; standardized perennial rye grass pollen; standardized redtop grass pollen; standardized sweet vernal grass pollen; standardized timothy grass pollen - liquid - 10000unit; 10000unit; 10000unit; 10000unit; 10000unit; 10000unit; 10000unit - standardized kentucky blue/june grass pollen 10000unit; standardized meadow fescue grass pollen 10000unit; standardized orchard grass pollen 10000unit; standardized perennial rye grass pollen 10000unit; standardized redtop grass pollen 10000unit; standardized sweet vernal grass pollen 10000unit; standardized timothy grass pollen 10000unit - allergenic extracts

Canada - Tiếng Anh - Health Canada

greer laboratories inc - standardized kentucky blue/june grass pollen; standardized meadow fescue grass pollen; standardized orchard grass pollen; standardized perennial rye grass pollen; standardized redtop grass pollen; standardized sweet vernal grass pollen; standardized timothy grass pollen - liquid - 100000unit; 100000unit; 100000unit; 100000unit; 100000unit; 100000unit; 100000unit - standardized kentucky blue/june grass pollen 100000unit; standardized meadow fescue grass pollen 100000unit; standardized orchard grass pollen 100000unit; standardized perennial rye grass pollen 100000unit; standardized redtop grass pollen 100000unit; standardized sweet vernal grass pollen 100000unit; standardized timothy grass pollen 100000unit - allergenic extracts

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

nelco laboratories, inc. - ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3) - ambrosia artemisiifolia pollen 20000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

antigen laboratories, inc. - salix lucida ssp. lasiandra pollen (unii: 9p9t267qmr) (salix lucida ssp. lasiandra pollen - unii:9p9t267qmr) - salix lucida ssp. lasiandra pollen 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

nelco laboratories, inc. - urochloa mutica pollen (unii: 3zo9ygz8zj) (urochloa mutica pollen - unii:3zo9ygz8zj) - urochloa mutica pollen 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t